Prediction of radiation pneumonitis in lung cancer patients: A systematic review

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 12, 2012, Pages 2103-2116

  Zhang, Xiao Jing ^a   Sun, Jian Guo ^a   Sun, Jie ^a   Ming, Hua ^a   Wang, Xin Xin ^a   Wu, Lei ^a   Chen, Zheng Tang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dose volume histogram; Lung cancer; Meta analysis; Radiation pneumonitis; Risk factors

Indexed keywords

ADULT; AGE; AGED; CELL HETEROGENEITY; CONTROLLED STUDY; DOSIMETRY; FEMALE; GENDER; HUMAN; LUNG CANCER; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS; RADIATION PNEUMONIA; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SYSTEMATIC REVIEW; TUMOR LOCALIZATION; TUMOR VOLUME; VALIDITY;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84871345103     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1284-1     Document Type: Review

References (83)

1. Abid SH, Malhotra V, Perry MC (2001) Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 13(4):242-248
2. An JY, Kwon SJ, Lee YS et al (2004) Factors predicting the development of radiation pneumonitis in the patients receiving radiation therapy for lung cancer. Tuberc Respir Dis 56(1):40-50
3. Anscher MS, Kong FM, Andrews K et al (1998) Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41(5):1029-1035
4. Antonadou D (2002) Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer. Semin Radiat Oncol 12(1 Suppl 1):50-58
5. Antonadou D, Coliarakis N, Synodinou M et al (2001) Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys 51(4):915-922
6. Antonadou D, Petridis A, Synodinou M et al (2003) Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer. Semin Oncol 30(6) Suppl 18):2-9
7. Barriger RB, Fakiris AJ, Hanna N, Yu M, Mantravadi P, Mcgarry RC (2010) Dose-volume analysis of radiation pneumonitis in nonsmall- cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel. Int J Radiat Oncol Biol Phys 78(5):1381-1386
8. Barriger RB, Forquer JA, Brabham JG et al (2012) A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 1(82):457-462
9. Cai Y, Zhou D (2011) Analysis of risk factors of radiation pneumonitis in non-small cell lung cancer. Chin J Nosocomiol 21(16):3357-3359 (article in Chinese)
10. Chang DT, Olivier KR, Morris CG et al (2006) The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys 65(1): 125-131
11. Choi NC (2003) Radioprotective effect of amifostine in radiation pneumonitis. Semin Oncol 30:10-17
12. Claude L, Pe'rol D, Ginestet C et al (2004) A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 71(2):175-181
13. Clenton SJ, Fisher PM, Conway J, Kirkbride P, Hatton MQ (2005) The use of lung dose-volume histograms in predicting postradiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma. Clin Oncol (R Coll Radiol) 17(8):599-603
14. Dang J, Li G, Lu X et al (2010) Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol 136(8):1169-1178
15. Das SK, Chen S, Deasy JO, Zhou S, Yin FF, Marks LB (2008) Combining multiple models to generate consensus: application to radiation-induced pneumonitis prediction. Med Phys 35(11): 5098-5109
16. De Petris L, Lax I, Sirze'n F, Friesland S (2005) Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer. Med Oncol 22(4):375-381
17. De Ruysscher D, Wanders R, van Haren E et al (2008) HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 71(1):132-138
18. Evans ES, Kocak Z, Zhou SM et al (2006) Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer. Cytokine 5(3-4):186-192
19. Fay M, Tan A, Fisher R, Mac Manus M, Wirth A, Ball D (2005) Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61(5):1355-1363
20. Fu XL, Huang H, Bentel G et al (2001) Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 50(4):899-908
21. Fujino M, Shirato H, Onishi H et al (2006) Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors. Cancer J 12(1):41-46
22. Hildebrandt MA, Komaki R, Liao Z et al (2010) Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5(8):e12402
23. Hope AJ, Lindsay PE, EI Naqa I et al (2006) Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 65(1):112-124
24. Huang EX, Hope AJ, Lindsay PE et al (2011) Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 50(1):51-60
25. Inoue A, Kunitoh H, Sekine I, Sumi M, Tokuuye K, Saijo N (2001) Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 49(3):649-655
26. Ishii Y, Kitamura S (1999) Soluble intercellular adhesion molecule-1 as an early detection marker for radiation pneumonitis. Eur Respir J 13(4):733-738
27. Kim TH, Cho KH, Pyo HR et al (2005) Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 235(1):208-215
28. Kim JY, Kim YS, Kim YK et al (2009) The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients. Radiat Oncol 4:59
29. Kobayashi H, Uno T, Isobe K et al (2010) Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer. Jpn J Clin Oncol 40(5):464-469
30. Kocak Z, Yu X, Zhou SM et al (2005) The impact of pre-radiotherapy surgery on radiation-induced lung injury. Clin Oncol (R Coll Radiol) 17(4):210-216
31. Komaki R, Lee JS, Kaplan B et al (2002) Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results. Semin Radiat Oncol 12(1) Suppl 1):46-49
32. Komaki R, Lee JS, Milas L et al (2004) Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58(5):1369-1377
33. Kong FM, Anscher MS, Sporn TA et al (2001) Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Int J Radiat Oncol Biol Phys 49(1):35-41
34. Kong FM, Hayman JA, Griffith KA et al (2006) Final toxicity results of a radiation-dose escalation study in patients with non-smallcell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65(4):1075-1086
35. Koto M, Tsujii H, Yamamoto N, Nishimura H, Yamada S, Miyamoto T (2007) Dosimetric factors used for thoracic X-ray radiotherapy are not predictive of the occurrence of radiation pneumonitis after carbon-ion radiotherapy. Tohoku J Exp Med 213(2):149-156
36. Lee SW, Choi EK, Lee JS et al (2003) Phase II study of threedimensional conformal radiotherapy and concurrent mitomycin- C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56(4):996-1004
37. Li Y, Zhu SC, Chi ZF (2007) Analysis on the risk factors of radiation pneumonitis after three-dimensional radiotherapy in lung cancer patients. Cancer Res Prev Treat 34(8):586-589 (article in Chinese)
38. Mak RH, Alexander BM, Asomaning K, et al (2011) A singlenucleotide polymorphism in the MTHFR (methylene tetrahydrofolate reductase) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy. Cancer. [Epub ahead of print]
39. Makimoto T, Tsuchiya S, Hayakawa K, Saitoh R, Mori M (1999) Risk factors for severe radiation pneumonitis in lung cancer. Jpn J Clin Oncol 29(4):192-197
40. Mao J, Kocak Z, Zhou S et al (2007) The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response. Int J Radiat Oncol Biol Phys 67(5):1360-1369
41. Matsuno Y, Satoh H, Ishikawa H, Kodama T, Ohtsuka M, Sekizawa K (2006) Simultaneous measurements of KL-6 and SP-D in patients undergoing thoracic radiotherapy. Med Oncol 23(1): 75-82
42. Mehta V (2004) Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer. Semin Oncol 31:42-46
43. Monson JM, Stark P, Reilly JJ et al (1998) Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 82(5):842-850
44. Nakayama Y, Makino S, Fukuda Y, Min KY, Shimizu A, Ohsawa N (1996) Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 34(2):459-467
45. Novakova-Jiresova A, Van Gameren MM, Coppes RP, Kampinga HH, Groen HJ (2004) Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol 71(2):183-189
46. Oh D, Ahn YC, Park HC, do Lim H, Han Y (2009) Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors. Jpn J Clin Oncol 39(3):151-157
47. Parashar B, Edwards A, Mehta R et al (2011) Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer. Am J Clin Oncol 34(2):160-164
48. Piotrowski T, Matecka-Nowak M, Milecki P (2005) Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Neoplasma 52(1):56-62
49. Ramella S, Trodella L, Mineo TC et al (2010) Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combinedmodality therapy. Int J Radiat Oncol Biol Phys 76(1): 110-115
50. Rancati T, Ceresoli GL, Gagliardi G et al (2003) Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 67(3):275-283
51. Robnett TJ, Machtay M, Vines EF et al (2000) Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48(1):89-94
52. Roeder F, Friedrich J, Timke C et al (2010) Correlation of patientrelated factors and dose-volume histogram parameters with the onset of radiation pneumonitis in patients with small cell lung cancer. Strahlenther Onkol 186(3):149-156
53. Saynak M, Higginson DS, Morris DE, Marks LB (2010) Current status of postoperative radiation for non-small-cell lung cancer. Semin Radiat Oncol 20:192-200
54. Schild SE, Stella PJ, Geyer SM et al (2003) The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 21(17):3201-3206
55. Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother 1(2):100-107
56. Segawa Y, Takigawa N, Kataoka M, Takata I, Fujimoto N, Ueoka H (1997) Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys 39(1):91-98
57. Shi A, Zhu G, Wu H, Yu R, Li F, Xu B (2010) Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensitymodulated radiotherapy. Radiat Oncol 5:35
58. Song H, Yu JM (2009) Effect of diabetes mellitus on the development of radiation pneumonitis in patients with non-small cell lung cancer. Chin J Oncol 1:45-47 (article in Chinese)
59. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol 25(9):603-605
60. Takahashi H, Imai Y, Fujishima T et al (2001) Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis. Eur Respir J 17(3):481-487
61. Tsujino K, Hirota S, Endo M et al (2003) Predictive value of dosevolume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55(1):110-115
62. Tucker SL, Jin H, Wei X et al (2010) Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 77(3):691-698
63. Uno T, Isobe K, Kawakami H et al (2006) Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent nonsmall- cell lung cancer. Int J Clin Oncol 11(1):55-59
64. Vinogradskiy Y, Tucker SL, Liao Z, Martel MK (2012) Investigation of the relationship between gross tumor volume location and pneumonitis rates using a large clinical database of non-smallcell lung cancer patients. Int J Radiat Oncol Biol Phys 82(5):1650-1658
65. Vogelius IS, Bentzen S (2010) Clinical factors associated with risk of radiation pneumonitis: a literature based meta-analysis. Radiother Oncol 96:S125-S126
66. Vujaskovic Z, Groen HJ (2000) TGF-beta, radiation-induced pulmonary injury and lung cancer. Int J Radiat Biol 76(4): 511-516
67. Wang LW, Fu XL, Clough R et al (2000) Can angiotensin-converting enzyme inhibitors protect against symptomatic radiation pneumonitis. Radiat Res 153(4):405-410
68. Wang Y, Wang L, Feng Q et al (2005) Factors predicting radiation toxicity in the treatment of three-dimensional conformal radiotherapy for lung cancer. Chin J Lung Cancer 8(5):454-458
69. (article in Chinese) Wang WH, Bao Y, Chen M et al (2006) Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer. Chin J Cancer 25(10):1279-1283 (article in Chinese)
70. Wang J, Qiao XY, Cao YK et al (2009) Analysis of correlated factors of radiation pneumonitis after three-dimensional conformal radiotherapy for non-small cell lung cancer. Chin J Clin Oncol 36(19):1086-1089 (article in Chinese)
71. Wang J, Qiao XY, Lu FH et al (2010) TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy. Chin J Cancer 29(3):325-329 (article in Chinese)
72. Watanabe H, Suga A, Tsuchihashi Y et al (1995) Clinical study of radiation pneumonitis over 10 years. Nihon Kyobu Shikkan Gakkai Zasshi 33(4):384-388
73. Xiao C, Ding HJ, Feng LC, Qu BL, Dou YQ (2010) Efficacy of Liangxue Jiedu Huoxue Decoction in prevention of radiation pneumonitis: a randomized controlled trial. J Chin Integr Med 8(7):624-628 (article in Chinese)
74. Xie SX, Li WX, Lin YR, Zou WC (2006) Three-dimensional conformal hypofractionated radiotherapy for non-small-cell lung cancer. Chin oncol 16(12):1034-1037 (article in Chinese)
75. Yamada M, Kudoh S, Hirata K, Nakajima T, Yoshikawa J (1998) Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 34(1):71-75
76. Yamano M, Ogino H, Shibamoto Y, Horii N (2007) Relationship between radiation pneumonitis and prognosis in patients with primary lung cancer treated by radiotherapy. Kurume Med J 54(3-4):57-63
77. Yin M, Liao Z, Huang YJ et al (2011) Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy. PLoS One 6(5):e20055
78. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC (2005) Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63(3):672-682
79. Yu X, Yang Z, Wang G et al (2011) Correlative factor analysis of radiation pneumonitis in 62 locally advanced NSCLC cases treated with 3DCRT. Mod Oncol 19(6):1120-1122 (article in Chinese)
80. Zhang B, Qiao TK (2010) Predictors of pulmonary lesion induced by three dimensional conformal radiotherapy combined with chemotherapy of np for iii stage non-small cell lung cancer. Cancer Res Prev Treat 37(5):578-581 (article in Chinese)
81. Zhang L, Yang M, Bi N et al (2010) ATM polymorphisms are associated with risk of radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 77(5):1360-1368
82. Zhao L, Wang L, Ji W et al (2007) Association between plasma angiotensin-converting enzyme level and radiation pneumonitis. Cytokine 37(1):71-75
83. Zhong J, Liu J, Chen WX (2007) Relationship between the plasma transforming growth factor-b1 levels and radiation-induced lung injury. Pract J cancer 22(5):468-471 (article in Chinese)